<DOC>
	<DOCNO>NCT00659724</DOCNO>
	<brief_summary>The purpose study collect information ease use thrombogenicity Polyflux HD-C4 Big Fresenius Optiflux 180NR 200NR dialyzer condition routine clinical use hemodialysis .</brief_summary>
	<brief_title>Ease Use Blood Clotting Gambro Polyflux HD-C4 Big Dialyzer</brief_title>
	<detailed_description>This ease use study involve use FDA 510 ( k ) clear hemodialyzer impact patient 's routine dialysis therapy . This study aim obtain feedback nursing technical staff regard use thrombogenicity Polyflux HD-C4 Big , Fresenius Optiflux 180NR 200NR dialyzer . The dialysis nursing staff complete ease use thrombogenicity assessment follow routine dialysis therapy . Any adverse event track study patient .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Hemodialysis patient 18 year age old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Dialyzer</keyword>
</DOC>